As a year marked by significant volatility in the pharmaceutical market comes to a close, Traphaco enters 2026 with a proactive mindset, a solidly reinforced foundation, and a strong determination to transform restructuring efforts into substantive and sustainable growth.
Affirming its position as a pioneering pharmaceutical enterprise committed to sustainable development, Traphaco continues to be honored at the 2025 program recognizing outstanding Vietnamese enterprises in brand building, product quality, and intellectual property management.
Among the 14 collectives commended under the official decision, Traphaco and Traphaco Hung Yen were the two representatives from the pharmaceutical manufacturing sector, recognized alongside leading drug testing institutions and frontline quality control centers nationwide.
At the “The Announcement Ceremony of Vietnam’s Sustainable Companies 2025,” Traphaco was announced among the Top 10 enterprises in the manufacturing sector and concurrently received the “CSI Star” title. These two distinctions reflect the program’s recognition of Traphaco’s consistent contributions throughout a decade of advancing sustainable development.
At the 25th Anniversary Ceremony of the Ho Chi Minh City Stock Exchange (HOSE) on December 3, 2025, Traphaco was honored as one of the exemplary listed companies contributing positively to the development of Vietnam’s stock market. The recognition not only highlights more than 17 years of Traphaco’s journey alongside HOSE, but also affirms the sustainable values the company has consistently pursued.
Over the course of nearly six months, Traphaco participated in and supported IC Master 2025 – the Talented Communicators Competition – as students explored, developed, and presented communication concepts centered around Net Zero, a sustainability direction increasingly embraced by the younger generation.
The 53rd Anniversary Ceremony of Traphaco’s Traditional Day took place in a dignified and warm atmosphere, marking the enduring journey of a pioneering pharmaceutical enterprise and opening a new chapter of determination for the years ahead.
On November 21, 2025, Traphaco Joint Stock Company solemnly held the CEO Handover Ceremony for the 2021-2026 Executive Term at the company’s Grand Hall. The event marked a significant leadership handover and opened a new phase of development for one of Vietnam’s leading pharmaceutical enterprises.
Effective November 10, 2025, the Board of Directors of Traphaco Joint Stock Company (Traphaco JSC) officially announced the appointment of Ms. Dao Thuy Ha as Chief Executive Officer (CEO) for the 2021-2026 term.
Continuing its momentum of organizational and technological transformation, Traphaco has officially established Traphaco Pharmaceutical One Member Limited Company – a dedicated logistics subsidiary that plays a pivotal role in advancing the company’s strategy for efficient and sustainable growth.
